Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04123353 · ClinicalTrials.gov registry record
Scan-Rescan Sub-Study of MS PATHS
A clinical trial, sponsored by Biogen.
- Completed
- Registry status
- 30
- Enrollment target
NCT04123353 is a clinical trial that has completed, run by Biogen. The registered enrollment target is 30 participants.
The verdict
NCT04123353 has completed, sponsored by Biogen.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
The primary objective of this sub-study is to calculate the reproducibility and other technical performance measures of various magnetic resonance imaging (MRI) image analysis algorithms in order to assess their suitability for detecting changes due to multiple sclerosis (MS) in a real-world setting in participants with MS. The secondary objective of this sub-study is to use the primary endpoint results to calibrate measurements across scanners within each MS PATHS center.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2017-02-11 |
| Est. Completion | 2017-05-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04123353
The ClinicalTrials.gov registry entry for NCT04123353 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Biogen, which has 334 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04123353 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04123353 about?
NCT04123353 is a clinical study titled "Scan-Rescan Sub-Study of MS PATHS". The primary objective of this sub-study is to calculate the reproducibility and other technical performance measures of various magnetic resonance imaging (MRI) image analysis algorithms in order to assess their suitability for detecting changes due to multiple sclerosis (MS) in a real-world setting...
What is the current status of trial NCT04123353?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2017-02-11. Estimated completion is 2017-05-09.
Who is sponsoring clinical trial NCT04123353?
This trial is sponsored by Biogen, which has 334 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.